Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCRT vs. Surgery + Adjuvant Therapy in ESCC
NCT06775652Phase 3Completed
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, carboplatin in Esophageal Squamous Cell Carcinoma (ESCC). Started Jan 2018; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT06775652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06775652.